Case Study
Transforming Oncology Research: IQVIA’s End-to-End Patient Experience Data Approach
Scientific expertise and technology converge to deliver end-to-end, fit-for-purpose, regulator-ready patient experience data
Feb 18, 2026
Explore how an end‑to‑end, patient‑focused data approach is helping oncology trials meet evolving FDA expectations while capturing meaningful patient experience data. This case study highlights how combining COA science, oncology‑specific eCOA capabilities, and real‑time data visibility enables sponsors to reduce patient burden, improve compliance, and generate regulator‑ready outcomes across complex oncology studies.

Related solutions

Contact Us